Free Trial

Sernova (OTCMKTS:SEOVF) Shares Down 2%

Sernova logo with Medical background

Shares of Sernova Corp. (OTCMKTS:SEOVF - Get Free Report) were down 2% during trading on Friday . The stock traded as low as $0.18 and last traded at $0.18. Approximately 11,245 shares changed hands during trading, a decline of 59% from the average daily volume of 27,321 shares. The stock had previously closed at $0.19.

Sernova Price Performance

The company has a quick ratio of 0.62, a current ratio of 0.62 and a debt-to-equity ratio of 0.14. The firm has a market capitalization of $55.28 million, a price-to-earnings ratio of -2.02 and a beta of 1.18. The stock has a 50 day moving average of $0.19 and a 200 day moving average of $0.27.

Sernova (OTCMKTS:SEOVF - Get Free Report) last issued its earnings results on Monday, September 16th. The company reported ($0.01) EPS for the quarter.

Sernova Company Profile

(Get Free Report)

Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

→ My grim warning about AI stocks (From Porter & Company) (Ad)

Should you invest $1,000 in Sernova right now?

Before you consider Sernova, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sernova wasn't on the list.

While Sernova currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Is Palantir Heading for a $50 Price Target?
Rate Cuts Fuel Volatility: How Long Could it Last?
SMCI Stock: Is a Rebound Coming?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines